Skip to main content

ESZOPICLONE

NDC 61919-033 · DIRECT RX

Generic nameESZOPICLONE
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)ESZOPICLONE
Strength2 mg/1
DEA scheduleCIV
Marketing categoryANDA

Packages

61919-033-10 — 10 TABLET, FILM COATED in 1 BOTTLE (61919-033-10)

61919-033-30 — 30 TABLET, FILM COATED in 1 BOTTLE (61919-033-30)

61919-033-60 — 60 TABLET, FILM COATED in 1 BOTTLE (61919-033-60)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

55111-617 — Eszopiclone, 55111-619 — Eszopiclone, 55111-629 — Eszopiclone, 55700-581 — Eszopiclone, 55700-610 — Eszopiclone, 55700-621 — Eszopiclone, 60429-632 — eszopiclone, 60429-633 — eszopiclone, 60429-634 — eszopiclone, 60760-526 — Eszopiclone, 63187-817 — Eszopiclone, 63187-843 — Eszopiclone, 63187-970 — Eszopiclone, 65862-967 — ESZOPICLONE, 65862-968 — ESZOPICLONE, 65862-969 — ESZOPICLONE, 68071-2403 — Eszopiclone, 68071-3376 — Eszopiclone, 68180-322 — Eszopiclone, 68180-323 — Eszopiclone, +73 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels